Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chengxuan Yu
Observed name:
C.H. Yu
Institutions:
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
Observed institutions:
Ningbo University,
Second Affiliated Hospital of Zhejiang University,
First Affiliated Hospital Zhejiang University,
Zhejiang University
ORCID:
0009-0005-8518-1326
Observed ORCID:
0009-0005-8518-1326
OpenAlex ID:
A5072979091
Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2023
·
Wenhua Sang
, Yiduo Zhou
, et al.
·
Cancer Discovery
·
68
LECT2 association with macrophage-mediated killing of Helicobacter pylori by activating NF-κB and nitric oxide production
2016
·
H.X. Shen
, L. Li
, et al.
·
Genetics and Molecular Research
·
23
PDF
Impact of protein corona and PEGylation on the accumulation and efficacy of lysosome-disrupting lipid nanoparticles in KRAS-mutated cancer
2024
·
Hang Yang
, Jiafeng Wang
, et al.
·
Nano Today
·
13
Liver metastasis or peritoneal metastasis: single-cell RNA sequencing reveals the organotropism in colorectal cancer is driven by distinct partial-EMT processes
2025
·
Chengxuan Yu
, Wei Lu
, et al.
·
Cancer Letters
·
7
A Conserved FABP5 high Macrophage Subset Promotes Fibrosis and Carcinogenesis in Advanced Liver Disease
2025
·
Wenhao Ge
, Lifeng Ma
, et al.
·
Liver International
·
4
Data from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S3 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
SUPPLEMENTARY DATA FIGURES from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S1 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S2 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Data from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S4 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Data from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
SUPPLEMENTARY DATA FIGURES from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
PDF
Supplementary Table S2 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S2 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S3 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S1 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S4 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S1 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Supplementary Table S4 from Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
2024
·
Wenhua Sang
, Yiduo Zhou
, et al.
Show more works
View as search
Works count:
21
Citation count:
115
H-index:
4
I10-index:
3
Year
Topic
Type